Matching slides 18,554
Current window 7,321-7,350
Pages 619
Rows per page 30
Component: Quoteclear collectionreset all

Component

7,321-7,350 of 18,554

filter-aware
09
The slide uses a table to highlight specific growth projections and includes a testimonial quote to undermine the company's narrative.Skillz, Inc. (SKLZ) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction2 hits
10
The slide uses a quote from a former employee and a direct excerpt from Google's policy to support its bearish thesis.Skillz, Inc. (SKLZ) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction2 hits
262
The slide presents a narrative of a specific medical failure involving a necrotic liver, alleging that TransMedics may be concealing damage from receiving centers.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
265
The slide uses a quote to highlight a perceived lack of transparency by the company.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
272
The slide uses a Q&A format to directly contradict claims made by the TransMedics CEO regarding reimbursement pass-through.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
276
The slide uses a Q&A format to highlight a specific expert's negative sentiment toward TransMedics.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
278
The slide uses a Q&A format to build a narrative of market abandonment.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
282
The slide uses a testimonial from a transplant surgeon to support a bearish thesis on the company's market position.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
287
The slide uses highlighted text to emphasize key negative findings regarding the OCS technology's performance metrics.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
296
The slide uses a direct quote from an expert to undermine the value proposition of the TransMedics device.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
297
The slide uses a quote-heavy structure to undermine the investment thesis for TransMedics (TMDX).TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
313
The slide uses a direct quote to highlight a competitive threat to TransMedics' business model.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
325
The slide uses a direct quote to frame the current market situation as overpriced and vulnerable to disruption, drawing an analogy to the Hepatitis C drug market.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
331
Includes a direct quote from a CEO of a major OPO regarding a surgeon's resignation due to safety concerns.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
335
The slide uses a Q&A format to highlight a specific failure in the procurement process.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
338
The slide uses a quote to highlight a perceived lack of transparency by the company.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
339
The slide presents a narrative of institutional failure and ethical concerns regarding medical device reporting.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
340
The slide uses a Q&A format to highlight a specific expert's negative experience with TransMedics equipment and corporate communication.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
341
The slide highlights a critical failure in safety protocols and regulatory compliance as perceived by an industry expert.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
342
The slide uses highlighted text to emphasize key allegations of non-reporting and unethical behavior.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
27
The slide uses a highly aggressive, polemical tone to frame the company as a failing entity.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller Beat · Critique of Twist's management and strategy2 hits
28
Uses the 'iceberg' metaphor to suggest deeper, hidden issues.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller Beat · Critique of Twist's management and strategy2 hits
33
Uses CEO quotes to frame management stock sales as a contradiction to company performance or long-term commitment.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller Beat · Critique of Twist's management and strategy2 hits
50
Uses aggressive, colloquial language ('dumpster fire', 'fastest pig at the county fair') to undermine the target company.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller Loop · Aha Moment2 hits
75
The slide uses a Q&A format to highlight the discrepancy between the company's 'tech' narrative and the reality of their 'manual-labor' operations.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 2 hits
76
The slide uses a Q&A transcript format to undermine the company's claims of automation.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 2 hits
81
Uses an expert quote to debunk the 'robot' claim and provides visual evidence of off-the-shelf Hamilton equipment.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 2 hits
82
The slide relies on a Q&A format with an anonymous ex-employee to undermine the company's claims of automation and efficiency.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 2 hits
84
The slide highlights the contradiction between the company's claims of high-tech automation and the reality of manual, labor-intensive lab work.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 2 hits
93
The slide uses a combination of summary text and a direct quote from an IDT ex-regional sales manager to frame the company's technology as a 'self-defeating gimmick'.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction2 hits